Another breast cancer study that aligns with the overall conclusions of Henderson et al. (142) found that PTHrP levels are downregulated in malignant compared with normal breast epithelia, but also low levels of nuclear localized PTHrP correlate with unfavorable clinical outcomes (143). The gene discussed is PTHLH; the disease is breast carcinoma.